We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bulk Pharmaceutical Manufacturer Gets Warning Letter
Bulk Pharmaceutical Manufacturer Gets Warning Letter
May 8, 2006
The FDA issued an April 7 warning letter to Cody Laboratories, a Cody, Wyo.-based bulk pharmaceuticals manufacturer, stating that an inspection conducted March 717, 2005 "found deviations from the current good manufacturing practice (cGMP) requirements" in the company's active pharmaceutical ingredient (API) product Hydromorphone HCI and finished drug product Morphine Sulfate Concentrate Oral Solution.